Ellicott City, MD, United States of America

Qin Qin

USPTO Granted Patents = 4 

Average Co-Inventor Count = 1.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Qin Qin

Introduction

Qin Qin is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of magnetic resonance imaging (MRI) with a total of 4 patents to his name. His work focuses on improving imaging techniques that are crucial for medical diagnostics.

Latest Patents

One of Qin Qin's latest patents is titled "Quantitative mapping of MRI relaxation parameters." This invention enhances magnetic resonance imaging by including T1, T2, or diffusion mapping with improved image resolution. The improved resolution is achieved by leveraging the delay in image acquisition to eliminate the partial volume effect of fluid in and around the tissue being imaged. Another significant patent is "Measurement of blood volume using Fourier-transform based velocity-selective pulse trains on MRI." This invention provides a system and method for determining blood volume in a subject without the need for exogenous contrast agents. This non-contrast-enhanced MRI method is particularly beneficial for monitoring disorders such as stroke and cancer.

Career Highlights

Qin Qin is affiliated with The Johns Hopkins University, where he continues to advance research in MRI technology. His innovative approaches have the potential to transform how medical professionals assess and monitor various health conditions.

Collaborations

Qin Qin has collaborated with notable colleagues, including Dan Zhu and Ruoxun Zi. Their combined expertise contributes to the ongoing advancements in MRI technology and its applications in healthcare.

Conclusion

Qin Qin's contributions to MRI technology through his patents demonstrate his commitment to enhancing medical imaging techniques. His work not only improves diagnostic capabilities but also prioritizes patient safety and cost-effectiveness.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…